The Cooper Companies, Inc. (NASDAQ:COO) Shares Sold by Burns Matteson Capital Management LLC

Burns Matteson Capital Management LLC lessened its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 4.9% during the 4th quarter, Holdings Channel reports. The firm owned 7,390 shares of the medical device company’s stock after selling 384 shares during the period. Burns Matteson Capital Management LLC’s holdings in Cooper Companies were worth $679,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in COO. Victory Capital Management Inc. grew its position in shares of Cooper Companies by 23.0% during the third quarter. Victory Capital Management Inc. now owns 3,950,119 shares of the medical device company’s stock worth $435,856,000 after buying an additional 737,726 shares in the last quarter. JPMorgan Chase & Co. increased its position in shares of Cooper Companies by 13.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company’s stock valued at $543,979,000 after purchasing an additional 573,908 shares during the last quarter. International Assets Investment Management LLC purchased a new stake in shares of Cooper Companies in the 3rd quarter valued at approximately $46,727,000. Swedbank AB lifted its position in shares of Cooper Companies by 14.0% during the 4th quarter. Swedbank AB now owns 1,629,602 shares of the medical device company’s stock worth $149,809,000 after purchasing an additional 200,000 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in Cooper Companies by 11.9% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,818,610 shares of the medical device company’s stock valued at $200,665,000 after buying an additional 194,118 shares during the last quarter. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Price Performance

Shares of NASDAQ:COO opened at $93.57 on Monday. The Cooper Companies, Inc. has a 52 week low of $84.76 and a 52 week high of $112.38. The company has a 50-day moving average price of $94.99 and a 200 day moving average price of $99.85. The company has a market cap of $18.67 billion, a P/E ratio of 47.98, a PEG ratio of 2.41 and a beta of 1.00. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share for the quarter, beating analysts’ consensus estimates of $1.00 by $0.04. The firm had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1.03 billion. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The company’s revenue for the quarter was up 9.8% compared to the same quarter last year. During the same period in the previous year, the business earned $0.87 earnings per share. Research analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on COO. Wells Fargo & Company lifted their price target on Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a report on Friday, December 6th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a report on Friday, December 6th. Citigroup cut their target price on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a report on Friday, December 6th. StockNews.com lowered shares of Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Finally, Morgan Stanley decreased their target price on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research note on Friday, December 6th. Three analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $117.00.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.